Takeda Canada

Patients are at the centre of everything we do
Takeda is a global pharmaceutical leader founded by Chobei Takeda I in 1781 in Osaka, Japan.
For over 235 years, we’ve aimed to make an impact on patients’ lives by translating science into life-changing medicines. Our commitment to bringing better health and brighter futures to people around the world is built on a sustainable portfolio of innovative medicines.
Our priority is the patient and placing the patient at the centre of everything we do. We build trust with our customers and patients by respecting our company values, Takeda-ism: Integrity, Fairness, Honesty and Perseverance. These values are integral to our business and how we conduct everything we do.
Our passion for healthcare and commitment to improving lives will enable us to make the next 235 years healthier and brighter for people around the world.
Takeda Canada: Becoming an admired specialty health care company

Takeda Canada’s Vision is to become one of the most admired specialty health care companies in Canada.
Takeda is delivering better health for Canadians through leading innovations in gastroenterology and oncology while also continuing to make our established primary care products available for patients.
Our unwavering commitment to our patients, passion for innovation, and deeply rooted collaborative spirit is helping to transform our company into a more effective, innovative and patient-centric organization.
Patients motivate and inspire us to do more
Takeda’s long-standing presence and expertise in general medicine gastrointestinal health positions the company well to be a key player in specialty gastroenterology. Takeda Canada has already launched its first biologic treatment, ENTYVIO™,  and the company’s first patient support program, YOURVANTAGE™. 
Takeda Canada’s first oncology treatment for multiple myeloma, NINLARO™,  is now available to Canadian patients. Takeda Oncology has more than 15 compounds in its pipeline.
Takeda Canada is also committed to ensuring the company’s established Primary Care products remain available for Canadian patients. More information about Our Medicines is available here. 
Our Canadian roots run deep
Takeda established operations in Canada in 2009 and now has over 120 employees across Canada. The company’s global history and strength gives Takeda Canada a solid foundation to build its operations and investments as it becomes an agile specialty care health care company focused on gastroenterology and oncology.
In addition to the treatments we bring to Canadians under the Takeda name, many Takeda medicines have been helping patients in Canada for years through partnerships with other companies prior to establishing our own operations in Canada. Well-known and successful Takeda products have been available for many years through other companies by or under licence from Takeda including:

ACTOS® (pioglitazone hydrochloride)
ATACAND® (candesartan cilexetil)
LUPRON® (leuprolide acetate)
PREVACID® (lansoprazole)
VELCADE® (bortezomib)


Takeda Pharma